SWX:ADXN

Addex Therapeutics Stock

SWITZERLAND |SW |CHF

Price
CHF1.45
Change
-1.69%
Today's Range
CHF1.45 - CHF1.48
52-Week Range
CHF1.41 - CHF2.15
Market Cap
CHF50.33M
Volume
5.54K

About Addex Therapeutics (SWX:ADXN)

(SWX:ADXN) Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. to develop mGluR2PAM compounds for the treatment of human health. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.
Show more

ADXN Stock Price

Statistics Highlights (SWX:ADXN)

Shares Outstanding 34.12M Beta 1.46
Public Float 14.03M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 7.00% Ex-Dividend Date
Held by Institutions 31.50% IPO Date -

ADXN Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue CHF3.61M CHF2.76M CHF6.04M
EBITDA CHF-12.41M CHF-14.32M CHF-1.42M
Net Income CHF-12.86M CHF-14.78M CHF-1.64M
Total Assets CHF20.18M CHF33.03M CHF42.21M
Total Cash CHF18.70M CHF31.54M CHF41.67M
Total Debt CHF CHF CHF
Jun 21 Mar 21 Dec 20
Revenue CHF992.60K CHF844.22K CHF1.82M
EBITDA CHF-4.58M CHF-2.53M CHF-2.03M
Net Income CHF-4.69M CHF-2.64M CHF-2.12M
Total Assets CHF21.53M CHF26.87M CHF20.18M
Total Cash CHF18.11M CHF25.22M CHF18.70M
Total Debt CHF CHF CHF

ADXN Stock Price History

Addex Therapeutics Daily Stock Price History

Date Open High Low Close Change Volume
Sep 27, 2021 CHF1.50 CHF1.50 CHF1.46 CHF1.48 -1.67% 14.90K

(SWX:ADXN) Stock Price FAQs

What is today's stock price of Addex Therapeutics (SWX:ADXN)?

  • The current stock price of Addex Therapeutics (SWX:ADXN) is CHF1.45.
  • Today ADXN stock price opened at CHF1.48 after previous close of CHF1.48.
  • During the day, Addex Therapeutics stock quote has varied from a low of CHF1.45 to a high of CHF1.48.

What is Addex Therapeutics's 52-week change?

  • ADXN 52-week high stock quote is CHF2.15, which is 48.30% above the current share price.
  • The Addex Therapeutics (SWX:ADXN) 52-week low stock price is CHF1.41, which is 3.10% below the current share price.
  • Addex Therapeutics share price volatility (52-week beta) is 1.46.

Addex Therapeutics (SWX:ADXN) FAQ

How Much is Addex therapeutics Worth?

Addex therapeutics's worth today based on market capitalisation is CHF50.33M

How much money does Addex therapeutics make?

Last quarter (ended on June 30 ,2021) Addex therapeutics generated a net income of CHF-4.69M, representing a 33.59% decrease compared to the same quarter a year before (ended on June 30 ,2020).
Last fiscal year (ended on December 31 ,2020) Addex therapeutics generated a net income of CHF-12.86M, representing a 13.00% decrease compare to the previous fiscal year (ended on December 31 ,2019).
View More Details on Addex therapeutics's “Financials” Section

How much dividend does Addex therapeutics Pay?

The current annualized dividend payout for ADXN stock is CHF0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Addex therapeutics's "Dividend" Section

What were Addex therapeutics’s last Earnings results?

For the last quarterly earnings period (ended on June 30, 2021) ADXN reported CHF-0.14 EPS for the quarter.
View More Details on Addex therapeutics's 'Earnings' Section

What is Addex therapeutics’s Price to Earning (PE) ratio?

ADXN stock also has a Price to Sales (P/S) ratio of 12.62, a Price to Book of 3.05 and Price/Earnings to Growth (PEG) of 0.00.

What is the Addex therapeutics's ticker?

Addex therapeutics trades on the SIX Swiss stock market in Switzerland under the ticker symbol "ADXN". Addex therapeutics’s stock symbol can also be displayed as "SWX:ADXN".

Who are the owners of Addex therapeutics?

Addex therapeutics (SWX:ADXN) is owned by 31.50% institutional shareholders and by 7.00% insiders. The rest is owned by the public.
Explore More Details on Addex therapeutics's “Ownership” Section

Who are the key executives of Addex therapeutics (ADXN)?

Addex therapeutics's key executive team includes the following managers:

  • Mr. Timothy Mark Dyer, Co-Founder, CEO & Director (1968)
  • Mr. Lénaic Teyssédou, Head of Fin. (1986)
  • Dr. Jean-Philippe Rocher Ph.D., Head of Discovery - Chemistry (1959)
  • Dr. Robert Lutjens, Head of Discovery - Biology (1968)
  • Dr. Roger G. Mills M.D., Chief Medical Officer & Director (1957)
  • Dr. Mikhail Kalinichev Ph.D., Head of Translational Science (NA)
  • Dr. Werner Henrichi Ph.D., Consultant (1943)

What is Addex therapeutics’s Sector & Industry Classification?

Addex therapeutics (SWX:ADXN) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Addex therapeutics?

Currently the number of employees working for Addex therapeutics is 27.

Where are Addex therapeutics's Headquarters?

Addex therapeutics (SWX:ADXN) is headquartered in Switzerland.

What are Addex therapeutics's Address and Phone Number?

Addex therapeutics’s mailing address is Chemin des Mines, 9, Geneva, Switzerland, 1202.
The company’s phone number is 41 22 884 1555.

What is the official website for Addex therapeutics?

Addex therapeutics’s official website is http://www.addextherapeutics.com